Jazz Pharmaceuticals (JAZZ) Profit After Tax Growth (1y) (2011 - 2026)
Jazz Pharmaceuticals (JAZZ) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 0.26% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -107.76% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 101.22% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.75 Bn | 13.91 Bn | 934.80 Mn | 416.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 416.86% |
| Dec 31, 2025 | 6.45% |
| Sep 30, 2025 | 16.91% |
| Jun 30, 2025 | -526.22% |
| Mar 31, 2025 | -129.83% |
| Dec 31, 2024 | 102.98% |
| Sep 30, 2024 | 46.48% |
| Jun 30, 2024 | 48.64% |
| Mar 31, 2024 | -127.70% |
| Dec 31, 2023 | 139.11% |
| Sep 30, 2023 | 847.25% |
| Jun 30, 2023 | 122.01% |
| Mar 31, 2023 | 8,720.83% |
| Dec 31, 2022 | -580.95% |
| Sep 30, 2022 | 62.81% |
| Jun 30, 2022 | -41.83% |
| Mar 31, 2022 | -98.65% |
| Dec 31, 2021 | -126.50% |
| Sep 30, 2021 | -135.64% |
| Jun 30, 2021 | -416.47% |